Cohance Lifesciences Ltd

Suven Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2023 inter alia to consider and approve With reference to above subject pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please note that a Meeting of the Board of Directors of the Company will be held on Tuesday the 8th August 2023 at 3:00 p.m. at the Registered Office SDE Serene Chambers 3rd Floor Road No 5 Banjara Hills Hyderabad - 500034 of the Company to consider inter alia and approve the following matter(s): To consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the first quarter ended June 30 2023 and related matters.Please further note that TRADING WINDOW for dealing in the securities of the company is already closed from 01st July 2023 as per PIT Code of the Company. Trading window will be opened from 11th August 2023.